These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 4402420)
1. Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects. Schröder H; Evans DA Gut; 1972 Apr; 13(4):278-84. PubMed ID: 4402420 [TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of sulphasalazine. Das KM; Dubin R Clin Pharmacokinet; 1976; 1(6):406-25. PubMed ID: 15752 [TBL] [Abstract][Full Text] [Related]
3. Genetically determined variability in acetylation and oxidation. Therapeutic implications. Clark DW Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977 [TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Klotz U Clin Pharmacokinet; 1985; 10(4):285-302. PubMed ID: 2864155 [TBL] [Abstract][Full Text] [Related]
5. Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis. Cowan GO; Das KM; Eastwood MA Br Med J; 1977 Oct; 2(6094):1057-9. PubMed ID: 21720 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of sulphasalazine in young and elderly patients with rheumatoid arthritis. Taggart AJ; McDermott B; Delargy M; Elborn S; Forbes J; Roberts SD; Ahnfelt NO Scand J Rheumatol Suppl; 1987; 64():29-36. PubMed ID: 2893450 [TBL] [Abstract][Full Text] [Related]
7. Sulphasalazine-induced leucopenia in a patient with renal dysfunction. Teshima D; Hino B; Makino K; Yano T; Itoh Y; Joh Y; Iida M; Oishi R J Clin Pharm Ther; 2003 Jun; 28(3):239-42. PubMed ID: 12795783 [TBL] [Abstract][Full Text] [Related]
8. Simplified method for determining acetylator phenotype. Schröder H Br Med J; 1972 Aug; 3(5825):506-7. PubMed ID: 4403571 [TBL] [Abstract][Full Text] [Related]
9. A comparison of serum concentrations of sulphasalazine and some of its metabolites after therapy by the oral or rectal route. Ashworth M; Arthur M; Turmer AD; Smith PR Pharmatherapeutica; 1984; 3(8):551-5. PubMed ID: 6142465 [TBL] [Abstract][Full Text] [Related]
10. Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Pullar T; Hunter JA; Capell HA Ann Rheum Dis; 1985 Dec; 44(12):831-7. PubMed ID: 2867746 [TBL] [Abstract][Full Text] [Related]
11. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review. Pullar T; Capell HA Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854 [TBL] [Abstract][Full Text] [Related]
12. Sulphasalazine for rheumatoid arthritis: relationship between dose, acetylator phenotype and response to treatment. Bax DE; Greaves MS; Amos RS Br J Rheumatol; 1986 Aug; 25(3):282-4. PubMed ID: 2873862 [TBL] [Abstract][Full Text] [Related]
13. The effect of the acetylator phenotype on the metabolism of sulphasalazine in man. Azad Khan AK; Nurazzaman M; Truelove SC J Med Genet; 1983 Feb; 20(1):30-6. PubMed ID: 6133000 [TBL] [Abstract][Full Text] [Related]
14. Azo reduction of sulphasalazine in healthy volunteers. Houston JB; Day J; Walker J Br J Clin Pharmacol; 1982 Sep; 14(3):395-8. PubMed ID: 6127096 [TBL] [Abstract][Full Text] [Related]
15. Relationship between the acetylator phenotype, plasma sulfapyridine levels and adverse effects during treatment with salicylazosulfapyridine in patients with chronic bowel diseases. Rahav G; Zylber-Katz E; Rachmilewitz D; Levy M Isr J Med Sci; 1990 Jan; 26(1):31-4. PubMed ID: 1968894 [TBL] [Abstract][Full Text] [Related]
16. Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Esbjörner E; Järnerot G; Wranne L Acta Paediatr Scand; 1987 Jan; 76(1):137-42. PubMed ID: 2882643 [TBL] [Abstract][Full Text] [Related]
17. Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Azad Khan AK; Howes DT; Piris J; Truelove SC Gut; 1980 Mar; 21(3):232-40. PubMed ID: 6105118 [TBL] [Abstract][Full Text] [Related]
18. Sulphasalazine and male infertility: reversibility and possible mechanism. Toovey S; Hudson E; Hendry WF; Levi AJ Gut; 1981 Jun; 22(6):445-51. PubMed ID: 6114897 [TBL] [Abstract][Full Text] [Related]